216 related articles for article (PubMed ID: 34306319)
1. LRRK2 Kinase Inhibitor Rejuvenates Oxidative Stress-Induced Cellular Senescence in Neuronal Cells.
Ho DH; Nam D; Seo MK; Park SW; Seol W; Son I
Oxid Med Cell Longev; 2021; 2021():9969842. PubMed ID: 34306319
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of the p53-p21 pathway by G2019S LRRK2 contributes to the cellular senescence and accumulation of α-synuclein.
Ho DH; Seol W; Son I
Cell Cycle; 2019 Feb; 18(4):467-475. PubMed ID: 30712480
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective Effect of the LRRK2 Kinase Inhibitor PF-06447475 in Human Nerve-Like Differentiated Cells Exposed to Oxidative Stress Stimuli: Implications for Parkinson's Disease.
Mendivil-Perez M; Velez-Pardo C; Jimenez-Del-Rio M
Neurochem Res; 2016 Oct; 41(10):2675-2692. PubMed ID: 27394417
[TBL] [Abstract][Full Text] [Related]
4. Rotenone Blocks the Glucocerebrosidase Enzyme and Induces the Accumulation of Lysosomes and Autophagolysosomes Independently of LRRK2 Kinase in HEK-293 Cells.
Perez-Abshana LP; Mendivil-Perez M; Velez-Pardo C; Jimenez-Del-Rio M
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445771
[TBL] [Abstract][Full Text] [Related]
5. Increase in anti-apoptotic molecules, nucleolin, and heat shock protein 70, against upregulated LRRK2 kinase activity.
Jang J; Oh H; Nam D; Seol W; Seo MK; Park SW; Kim HG; Seo H; Son I; Ho DH
Anim Cells Syst (Seoul); 2018; 22(5):273-280. PubMed ID: 30460108
[TBL] [Abstract][Full Text] [Related]
6. Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble α-synuclein in neurons.
Schapansky J; Khasnavis S; DeAndrade MP; Nardozzi JD; Falkson SR; Boyd JD; Sanderson JB; Bartels T; Melrose HL; LaVoie MJ
Neurobiol Dis; 2018 Mar; 111():26-35. PubMed ID: 29246723
[TBL] [Abstract][Full Text] [Related]
7. LRRK2 kinase inhibition protects against Parkinson's disease-associated environmental toxicants.
Ilieva NM; Hoffman EK; Ghalib MA; Greenamyre JT; De Miranda BR
Neurobiol Dis; 2024 Jun; 196():106522. PubMed ID: 38705492
[TBL] [Abstract][Full Text] [Related]
8. Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21(WAF1/CIP1) expression.
Ho DH; Kim H; Kim J; Sim H; Ahn H; Kim J; Seo H; Chung KC; Park BJ; Son I; Seol W
Mol Brain; 2015 Sep; 8():54. PubMed ID: 26384650
[TBL] [Abstract][Full Text] [Related]
9. Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA).
Ho PW; Leung CT; Liu H; Pang SY; Lam CS; Xian J; Li L; Kung MH; Ramsden DB; Ho SL
Autophagy; 2020 Feb; 16(2):347-370. PubMed ID: 30983487
[TBL] [Abstract][Full Text] [Related]
10. LRRK2 Knockout Confers Resistance in HEK-293 Cells to Rotenone-Induced Oxidative Stress, Mitochondrial Damage, and Apoptosis.
Quintero-Espinosa DA; Sanchez-Hernandez S; Velez-Pardo C; Martin F; Jimenez-Del-Rio M
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445652
[TBL] [Abstract][Full Text] [Related]
11. Constitutive silencing of LRRK2 kinase activity leads to early glucocerebrosidase deregulation and late impairment of autophagy in vivo.
Albanese F; Mercatelli D; Finetti L; Lamonaca G; Pizzi S; Shimshek DR; Bernacchia G; Morari M
Neurobiol Dis; 2021 Nov; 159():105487. PubMed ID: 34419621
[TBL] [Abstract][Full Text] [Related]
12. Microglial LRRK2-mediated NFATc1 attenuates α-synuclein immunotoxicity in association with CX3CR1-induced migration and the lysosome-initiated degradation.
Feng L; Lo H; Hong Z; Zheng J; Yan Y; Ye Z; Chen X; Pan X
Glia; 2023 Sep; 71(9):2266-2284. PubMed ID: 37300531
[TBL] [Abstract][Full Text] [Related]
13. Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson's disease.
Liu HF; Ho PW; Leung GC; Lam CS; Pang SY; Li L; Kung MH; Ramsden DB; Ho SL
Sci Rep; 2017 Jan; 7():40887. PubMed ID: 28098219
[TBL] [Abstract][Full Text] [Related]
14. LRRK2 inhibition does not impart protection from α-synuclein pathology and neuron death in non-transgenic mice.
Henderson MX; Sengupta M; McGeary I; Zhang B; Olufemi MF; Brown H; Trojanowski JQ; Lee VMY
Acta Neuropathol Commun; 2019 Feb; 7(1):28. PubMed ID: 30808409
[TBL] [Abstract][Full Text] [Related]
15. High Yield of Functional Dopamine-like Neurons Obtained in NeuroForsk 2.0 Medium to Study Acute and Chronic Rotenone Effects on Oxidative Stress, Autophagy, and Apoptosis.
Quintero-Espinosa DA; Velez-Pardo C; Jimenez-Del-Rio M
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958728
[TBL] [Abstract][Full Text] [Related]
16. LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease.
Rocha EM; De Miranda BR; Castro S; Drolet R; Hatcher NG; Yao L; Smith SM; Keeney MT; Di Maio R; Kofler J; Hastings TG; Greenamyre JT
Neurobiol Dis; 2020 Feb; 134():104626. PubMed ID: 31618685
[TBL] [Abstract][Full Text] [Related]
17. LRRK2 kinase inhibitors reduce alpha-synuclein in human neuronal cell lines with the G2019S mutation.
Zhao Y; Keshiya S; Perera G; Schramko L; Halliday GM; Dzamko N
Neurobiol Dis; 2020 Oct; 144():105049. PubMed ID: 32800998
[TBL] [Abstract][Full Text] [Related]
18. Preclinical modeling of chronic inhibition of the Parkinson's disease associated kinase LRRK2 reveals altered function of the endolysosomal system in vivo.
Kluss JH; Mazza MC; Li Y; Manzoni C; Lewis PA; Cookson MR; Mamais A
Mol Neurodegener; 2021 Mar; 16(1):17. PubMed ID: 33741046
[TBL] [Abstract][Full Text] [Related]
19. Alpha-Synuclein Preformed Fibrils Induce Cellular Senescence in Parkinson's Disease Models.
Verma DK; Seo BA; Ghosh A; Ma SX; Hernandez-Quijada K; Andersen JK; Ko HS; Kim YH
Cells; 2021 Jul; 10(7):. PubMed ID: 34359864
[TBL] [Abstract][Full Text] [Related]
20. The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson's disease.
De Miranda BR; Castro SL; Rocha EM; Bodle CR; Johnson KE; Greenamyre JT
Neurobiol Dis; 2021 Jun; 153():105312. PubMed ID: 33636387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]